Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. (Q51202531)
Jump to navigation
Jump to search
scientific article published on 4 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. |
scientific article published on 4 January 2013 |
Statements
Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams (English)
C Bucci-Rechtweg
G Su
T F Hue
P Mesenbrink
K W Lyles
S Boonen
HORIZON Pivotal Fracture Trial and HORIZON Recurrent Fracture Trial Steering Committees